Apalutamide 60 mg is a next-generation androgen receptor inhibitor used in Australia for the treatment of castration-resistant prostate cancer (CRPC). Apnat 60 mg helps delay disease progression in men with non-metastatic or metastatic prostate cancer.
| |||||||||||||||||||||
Apalutamide 60 mg Australia
Price range: $538.00 through $1,162.35
Reviews (1)
Seth Burnell –
Apalutamide 60 mg was prescribed as part of my ongoing therapy.